Please try another search
TCM Biosciences Inc. researches, develops, and sells in-vitro diagnostics and reagents. It offers reagents, instruments, and systems, including liquid based cytology processors, cervical cancer HPV/STI self-collection kits, and STD self test kits for use in the collection, preparation, and examination of specimens taken and diagnosed outside the human body. The company also provides molecular diagnosis tools for the detection and analysis of diseases/infections, such as cancer risk evaluation, anti-aging Mitochondria activity analysis, respiratory pathogens, sexually transmitted infections, human Papillomavirus screening, tuberculosis, BRAF codeon V600E, ApoE genotyping, and avellino corneal dystrophy. TCM Biosciences Inc. was founded in 2009 and is based in Seongnam, South Korea. As of July 17, 2020, TCM Biosciences Inc. operates as a subsidiary of Next Bt Co., Ltd.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review